control group:Kangxianhuanji Granule placebo combined with conventional treatment

2 trials

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine

Conditions

AE-IPF

Early Phase 1

Kangxianhuanji Granules in the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis: a Randomized, Controlled Exploratory Clinical Study

RecruitingITMCTR1900002632

The First Affiliated Hospital of Henan University of Chinese MedicineAE-IPF

Start: 2019-10-01Updated: 2023-02-20

Kangxianhuanji Granules in the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis: a Randomized, Controlled Exploratory Clinical Study

RecruitingChiCTR1900026289

The First Affiliated Hospital of Henan University of Chinese MedicineAE-IPF

Start: 2019-10-01Updated: 2019-09-30

Related Papers

Efficacy and safety of Kangxian Huanji Granule as adjunctive treatment in acute exacerbation of idiopathic pulmonary fibrosis: An exploratory randomized controlled trial.

2023-11-083 citations

Efficacy and safety of traditional Chinese medicine in patients with acute exacerbation of idiopathic pulmonary fibrosis: study protocol for randomized, controlled, exploratory clinical trial.

2022-02-024 citations